Login / Signup

Long-Term Burosumab Administration is Safe and Effective in Adults With X-Linked Hypophosphatemia (XLH).

Thomas J WeberErik Allen ImelThomas O CarpenterMunro PeacockAnthony A PortaleJoel HetzerJ Lawrence MerrittKarl Insogna
Published in: The Journal of clinical endocrinology and metabolism (2022)
These data support the conclusion that burosumab therapy may be a safe and effective long-term treatment option for adult patients with XLH.
Keyphrases
  • electronic health record
  • big data
  • stem cells
  • machine learning
  • mesenchymal stem cells
  • deep learning
  • bone marrow
  • artificial intelligence
  • data analysis